Upload
antti
View
219
Download
0
Embed Size (px)
Citation preview
CASE REPORTS
Severe tick-borne encephalitis in a patient previously infected byWest Nile virus
EMOKE FERENCZI1, ENIKO BAN1, ANITA ABRAHAM2, TAMASNE KAPOSI1,
GABOR PETRANYI1, GYORGY BERENCSI1 & ANTTI VAHERI3
From the 1National Reference Laboratory for Viral Zoonoses, Department of Virology, National Centre for Epidemiology,
Budapest, 2St. Laszlo Central Hospital for Infectious Diseases, Budapest, Hungary, and 3Department of Virology, Haartman
Institute, University of Helsinki, Helsinki, Finland
AbstractWe describe severe tick-borne encephalitis (TBE) in a patient who had previously experienced West Nile fever, anotherflavivirus infection endemic in Hungary. Previous West Nile virus infection does not develop immunity either against TBEvirus infection or the disease, and it does not mitigate its clinical course. The possibility of antibody-dependentenhancement is considered.
Introduction
In the early 1960s it became obvious that tick-borne
encephalitis (TBE) is a significant public health
concern in Hungary. Endemic areas of TBE were
shaped through the systematic search for natural foci
of arboviruses between 1966 and 1986 [1], as well as
by viral diagnostics of suspected TBE patients [2].
The first indigenous human infections by West Nile
virus (WNV), characterized by neurological symp-
toms (meningitis, encephalitis), were diagnosed in
Hungary in 2003, but no animal cases had been
detected to date. 14 human cases were confirmed
serologically and a WNV outbreak at a goose farm
[3,4]. These events raised several questions: had the
virus already established itself in Hungary, did
migratory birds bring the virus to the country every
y, and what would be the consequences of consecu-
tive infections/immunizations of the 2 viruses, TBEV
and WNV, in humans? While the first 2 questions
remain unanswered, the present case report sheds
light on the third.
Case report
A 38-y-old female who lived in a small village in north-
eastern Hungary became seriously ill in the autumn of
2005 after a tick bite during an outing to the hills near
her village. She had a history of ulcerative colitis, had
not been vaccinated against TBE and had never been
abroad. 10 d after the tick bite she fell ill and was
admitted 1 d later to the Department of Neurology of
the local county hospital. Her initial symptoms were
malaise, nausea and generalized muscle pains. Be-
cause of her rapidly worsening condition she was
transferred to the Hungarian Central Hospital for
Infectious Diseases after 3 d of treatment. Upon her
second hospital admission, on d 14 after the tick bite,
the patient’s symptoms were fever, neck stiffness,
vertigo, severe neck pain radiating to the back and
difficulties in walking. During the next 3 d, hypotonia,
areflexia, and right upper limb paralysis developed.
There was no sensory involvement. Methylpredniso-
lone therapy (10 g total) was started and gradual
recovery followed. On d 27, mild paresis appeared in
the left upper limb. She recovered with sequelae�residual right arm weakness and right shoulder
muscle atrophy.
At the acute stage her cerebrospinal fluid had 525
WBC/l (95% polymorphonuclear cells), increased
protein (1.3 g/l) and normal glucose. An MRI scan
of the cervical spine excluded any compressive
lesion, but showed enlargement of the cervical cord
Correspondence: A. Vaheri, Department of Virology, Haartman Institute, POB 21, FIN-00014 University of Helsinki, Finland. Tel: �358 9 1912 6490.
E-mail: [email protected]
Scandinavian Journal of Infectious Diseases, 2008; 40: 759�766
(Received 14 February 2008; accepted 18 February 2008)
ISSN 0036-5548 print/ISSN 1651-1980 online # 2008 Informa UK Ltd. (Informa Healthcare, Taylor & Francis As)
DOI: 10.1080/00365540801995386
Scan
d J
Infe
ct D
is D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y Fr
anci
s A
Cou
ntw
ay L
ibra
ry o
f M
edic
ine
on 0
8/13
/13
For
pers
onal
use
onl
y.
from C3 to C7 and signal disturbance due to
oedema and inflammation. Nerve conduction stu-
dies and concentric needle electromyography
showed severe damage of the right cervical anterior
horn cells (lower motor neurons) with concomitant
increase in distal latency of median nerve and signs
of denervation in the C5 and C6 myotomes.
The first serum sample was sent to the virus
laboratory with clinical diagnosis of TBE. Three
methods were used for the determination of specific
antibodies: 1) indirect fluorescent antibody assay
(IFA) on in-house slides; 2) haemagglutination in-
hibition test (HI) using in-house HA antigen pre-
pared from the first Hungarian TBEV isolate
(KEM1); and 3) a commercial ELISA test (Nova-
Tec). Reliability of the in-house tests was evaluated in
an external quality assurance (EQA) programme for
the serological diagnosis of TBEV infections, and the
tests proved to be suitable for this purpose [5].
Because of the difficulties in the detection of specific
IgM by the 3 methods used, the examinations were
extended to the detection of specific antibodies
directed against WNV. Both IFA and HI were
performed using in-house antigens, while the ELISA
was performed for IgM with a commercial ELISA kit
(PanBio). In spite of the very high titres of WNV-
specific IgG, IgM antibodies remained undetectable.
Results of specific IgM had been negative or doubtful
for both viruses. The kinetics of the immune response
indicated that she had earlier encountered WNV
infection (probably without severe symptoms) and
now suffered from a current TBEV infection. Table I
shows the serological results of the patient’s consecu-
tive 3 serum samples, except for the IgM results.
Historical data and conclusions
TBE-endemic foci in Hungary are well known since
the early 1960s, while WNV circulation and infec-
tions in human and animal individuals became
obvious only in 2003. The Transdanubian region
as well as the north-eastern part of Hungary are
endemic for TBE, the Hungarian Great Plains have
only very small TBE foci but seem to be endemic for
WNV. There are very few overlapping areas as yet.
Recent results have shown that WNV has established
itself in some parts of Hungary [4].
This is the first report on sequential natural
infections with WNV and TBEV in humans. The
case described here showed that the previous WNV
infection does not develop immunity against TBEV
infection or the disease, and does not mitigate the
clinical course of the disease.
Diagnostics of flavivirus infections are performed
centrally in Hungary. Since 1981 the IFA method
has been used as a daily routine and HI to confirm
the results. Using these 2 methods the laboratory can
diagnose most of the acute infections as well as
evaluate immunity after vaccination and, if not, an
additional virus neutralization test can be per-
formed. Typical antibody titres in the diagnostic
laboratory are 80�160 and 80�320 using IgG-IFA
and HI in sera taken on d 6�14, and 160�640 and
320�640 taken on d 15�42 after the onset of
symptoms. Specific IgM has been detectable during
this period by both methods in sera fractionated by
chromatography [6]. The IgM fraction corresponds
to about 1:10 dilution of the original serum and
contains also IgA. In primary WNV infections IgG
titres proved to be at least 4-fold higher than in
TBEV infections (data not shown).
During the past 25 y the National Reference
Laboratory has diagnosed about 30 TBE cases
with vaccination in their anamnestic data. The
immune response of most of these patients was
similar to the 1 described above. Notably, in most
patients the course of the disease has been more
severe than in the patients without former vaccina-
tion (Ferenczi, Mikola, Guseo, unpublished obser-
vations). Similar clinical observations have been
described in children who had developed severe
TBE despite post-exposure prophylaxis with specific
TBE immunoglobulin [7]. It is difficult to say
whether the present case is more severe than usual,
as the manifestations of TBEV infections can range
from asymptomatic to fatal illness. However, the
outcome of most TBE cases remains without seque-
lae in Hungary, and paresis and the consequent
muscular atrophy of the upper limbs are rare. Similar
data have been found in other European countries
Table I. Reciprocal virus serology titres of the patient infected consecutively by WNV and TBEV.
Antibodies to TBEV Antibodies to WNV
D after onset of symptoms Sample IgG-IFA HI IgG-IFA HI
6 Serum 640�1280 1280 1280�2560 ]10240
6 CSFa 2�4 8�16 2�4 16�32
8 Serum ]2560 2560�5120 ]2560 5120
43 Serum ]2560 ]10240 320 640
aCerebrospinal fluid.
760 Case Reports
Scan
d J
Infe
ct D
is D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y Fr
anci
s A
Cou
ntw
ay L
ibra
ry o
f M
edic
ine
on 0
8/13
/13
For
pers
onal
use
onl
y.
[8,9]. In this patient the very rapid transportation
from the local hospital to the Central Hospital for
Infectious Diseases (St. Laszlo Hospital, Budapest)
emphasizes the sudden onset of the severe disease,
which is not an everyday event in Hungary. The
short incubation period of 2 weeks to neurological
symptoms, compared to the usual 3 weeks, suggests
that antibody-dependent enhancement (ADE) may
have occurred.
Several factors (e.g. low antigen content in the
vaccine, negligence around the immunization sche-
dule, vaccination in the tick season, vaccination or
infection with another flavivirus, post-exposure pre-
vention with a small amount of specific immunoglo-
bulin preparation) could be traced as sources for the
suboptimal immune status [10]. In vitro studies on
ADE in TBE have suggested that the enhancement
might be group- rather than flavivirus-specific [11].
In our case the 2 viruses, WNV and TBEV, belong to
2 different serological groups but are still highly
cross-reactive. Model experiments in experimentally
infected animals might explain the events in the case
of consecutive infections by the 2 viruses.
Preventive measures, including vector control and
correct vaccination practice, are needed to avoid the
enhanced disease manifestation in flavivirus infec-
tions. More attention should be paid to the complete
flavivirus surveillance, especially in countries where
more than 1 flavivirus causes human illnesses.
References
[1] Molnar E. Occurrence of tick-borne encephalitis and other
arboviruses in Hungary. Geographia Medica 1982;/12:/78�120.
[2] Ferenczi E, Racz G, Faludi G, Czegledi A, Mezey I, Berencsi
G. Natural foci of classical and emerging viral zoonoses in
Hungary. In: Berencsi G, Khan AS, Halouzka J, editors.
NATO Science Series: Emerging Biological Threat. IOS
Press 2005;370:43�9.
[3] Glavits R, Ferenczi E, Ivanics E, Bakonyi T, Mato T, Zarka
P, et al. Co-occurrence of West Nile fever and circovirus
infection in a goose flock in Hungary. Avian Pathol 2005;/34:/
408�14.
[4] Bakonyi T, Ivanics E, Erdelyi K, Ursu K, Ferenczi E,
Weissenbock H, et al. Lineage 1 and 2 strains of encephalitic
West Nile virus, Central Europe. Emerg Infect Dis 2006;/12:/
618�23.
[5] Niedrig M, Avsic T, Aberle SW, Ferenczi E, Labuda M,
Rozentale B, et al. Quality control assessment for the
serological diagnosis of tick-borne encephalitis virus infec-
tions. J Clin Virol 2007;/38:/260�4.
[6] Nagy G, Mezey I. The use of ion exchange chromatography
for demonstration of rubella-specific IgM antibodies. Acta
Microbiol Acad Sci Hung 1977;/24:/189�94.
[7] Kluger G, Schottler A, Waldvogel K, Nadal D, Hinrichs W,
Wundisch GF, et al. Tick-borne encephalitis despite specific
immunoglobulin prophylaxis. Lancet 1995;/346:/1502.
[8] Kaiser R. The clinical and epidemiological profile of tick-
borne encephalitis in southern Germany 1994�1998: a
prospective study of 656 patients. Brain 1999;/122:/2067�78.
[9] Plısek S, Honegr K, Beran J. TBE infection in an incomplete
immunized person at risk who lives in a high-endemic area:
impact on current recommendations for immunization of
high-risk groups. Vaccine 2008;/26:/301�4.
[10] Ferenczi E, Jankovics A, Molnar E, Berencsi G. Does the
suboptimal antibody level aggravate the course of tick-borne
encephalitis? Acta Microbiol Immunol Hung 1999;/46:/394�5.
[11] Phillpotts RJ, Stephenson JR, Porterfield JS. Antibody-
dependent enhancement of tick-borne encephalitis virus
infectivity. J Gen Virol 1985;/66:/1831�7.
Six cases of Aerococcus sanguinicola infection: Clinical relevanceand bacterial identification
KRISTINA IBLER1, KJELD TRUBERG JENSEN2, CHRISTIAN ØSTERGAARD3,
UTE WOLFF SONKSEN4, BRITA BRUUN4, HENRIK C. SCHØNHEYDER5,
MICHAEL KEMP1, RIMTAS DARGIS1, KELD ANDRESEN1 &
JENS JØRGEN CHRISTENSEN1
From the 1Department of Bacteriology, Mycology and Parasitology, Statens Serum Institute, Copenhagen, and Departments of
Clinical Microbiology at 2Sydvestjysk Sygehus Esbjerg, 3Copenhagen University Hospital Herlev, 4Hillerød Hospital, and5Aalborg Hospital, Aarhus University Hospital, Denmark
Correspondence: K. Ibler, Department of Bacteriology, Mycology and Parasitology, Statens Serum Institute, Artillerivej 5, 2300 Copenhagen S, Denmark.
Tel: �45 32683647. Fax: �45 32683873. E-mail: [email protected]
Case Reports 761
(Received 24 March 2008; accepted 25 March 2008)
ISSN 0036-5548 print/ISSN 1651-1980 online # 2008 Informa UK Ltd. (Informa Healthcare, Taylor & Francis As)
DOI: 10.1080/00365540802078059
Scan
d J
Infe
ct D
is D
ownl
oade
d fr
om in
form
ahea
lthca
re.c
om b
y Fr
anci
s A
Cou
ntw
ay L
ibra
ry o
f M
edic
ine
on 0
8/13
/13
For
pers
onal
use
onl
y.